Seino, Y., Hiroi, S., Hirayama, M., & Kaku, K. (2012). Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study. Wiley-Blackwell.
Citación estilo ChicagoSeino, Yutaka, Shinzo Hiroi, Masashi Hirayama, and Kohei Kaku. Efficacy and Safety of Alogliptin Added to Sulfonylurea in Japanese Patients With Type 2 Diabetes: A Randomized, Double‐blind, Placebo‐controlled Trial With an Open‐label, Long‐term Extension Study. Wiley-Blackwell, 2012.
Cita MLASeino, Yutaka, Shinzo Hiroi, Masashi Hirayama, and Kohei Kaku. Efficacy and Safety of Alogliptin Added to Sulfonylurea in Japanese Patients With Type 2 Diabetes: A Randomized, Double‐blind, Placebo‐controlled Trial With an Open‐label, Long‐term Extension Study. Wiley-Blackwell, 2012.